Alcoholic Liver Disease in Asia, Europe, and North America

被引:141
作者
Liangpunsakul, Suthat [1 ,2 ]
Haber, Paul [3 ]
McCaughan, Geoffrey W. [4 ]
机构
[1] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, 550 N Univ Blvd,UH 4100, Indianapolis, IN 46202 USA
[2] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA
[3] Univ Sydney, Sydney Med Sch, Royal Prince Alfred Hosp, Drug Hlth Serv, Sydney, NSW 2006, Australia
[4] Univ Sydney, Royal Prince Alfred Hosp, Australian Liver Transplant Unit, Centenary Res Inst,AW Morrow GE Liver Ctr, Sydney, NSW 2006, Australia
关键词
Clinical Profiles; Alcoholic Liver Disease; Asia; Europe; North America; DISORDERS IDENTIFICATION TEST; CIRRHOSIS MORTALITY-RATES; FATTY LIVER; GENETIC POLYMORPHISMS; UNITED-STATES; RISK-FACTOR; PROMOTER POLYMORPHISM; SOCIOECONOMIC-STATUS; RSAI POLYMORPHISM; GLOBAL BURDEN;
D O I
10.1053/j.gastro.2016.02.043
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Alcoholic liver diseases comprise a spectrum of clinical disorders and changes in liver tissue that can be detected by pathology analysis. These range from steatosis to more severe signs and symptoms of liver disease associated with inflammation, such as those observed in patients with alcoholic hepatitis or cirrhosis. Although the relationship between alcohol consumption and liver disease is well established, severe alcohol-related morbidities develop in only a minority of people who consume alcohol in excess. Inter-individual differences in susceptibility to the toxic effects of alcohol have been studied extensively-they include pattern of alcohol consumption, sex, environmental factors (such as diet), and genetic factors, which vary widely among different parts of the world. Alcoholic liver disease is becoming more common in many parts of Asia, but is decreasing in Western Europe. Treatment approaches, including availability of medications, models of care, and approach to transplantation, differ among regions.
引用
收藏
页码:1786 / 1797
页数:12
相关论文
共 118 条
  • [91] Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis : A Randomized Pilot Study
    Singh, Virendra
    Sharma, Arun K.
    Narasimhan, R. Lakshmi
    Bhalla, Ashish
    Sharma, Navneet
    Sharma, Ratiram
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (09) : 1417 - 1423
  • [92] PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease
    Sookoian, Silvia
    Pirola, Carlos J.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (42) : 6018 - 6026
  • [93] The Role of Lipid Metabolism in the Pathogenesis of Alcoholic and Nonalcoholic Hepatic Steatosis
    Sozio, Margaret S.
    Liangpunsakul, Suthat
    Crabb, David
    [J]. SEMINARS IN LIVER DISEASE, 2010, 30 (04) : 378 - 390
  • [94] Genetic Variation in the PNPLA3 Gene Is Associated with Alcoholic Liver Injury in Caucasians
    Stickel, Felix
    Buch, Stephan
    Lau, Katharina
    Schwabedissen, Henriette Meyer zu
    Berg, Thomas
    Ridinger, Monika
    Rietschel, Marcella
    Schafmayer, Clemens
    Braun, Felix
    Hinrichsen, Holger
    Guenther, Rainer
    Arlt, Alexander
    Seeger, Marcus
    Mueller, Sebastian
    Seitz, Helmut Karl
    Soyka, Michael
    Lerch, Markus M.
    Lammert, Frank
    Sarrazin, Christoph
    Kubitz, Ralf
    Haeussinger, Dieter
    Hellerbrand, Claus
    Broering, Dieter
    Schreiber, Stefan
    Kiefer, Falk
    Spanagel, Rainer
    Mann, Karl
    Datz, Christian
    Krawczak, Michael
    Wodarz, Norbert
    Voelzke, Henry
    Hampe, Jochen
    [J]. HEPATOLOGY, 2011, 53 (01) : 86 - 95
  • [95] Stinson FS, 2001, ALCOHOL CLIN EXP RES, V25, P1181
  • [96] Alcohol and alcohol-related harm in China: policy changes needed
    Tang, Yi-lang
    Xiang, Xiao-jun
    Wang, Xu-yi
    Cubells, Joseph F.
    Babor, Thomas F.
    Hao, Wei
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2013, 91 (04) : 270 - 276
  • [97] Treatments for Alcohol-Related Disorders in China: A Developing Story
    Tang, Yi-Lang
    Hao, Wei
    Leggio, Lorenzo
    [J]. ALCOHOL AND ALCOHOLISM, 2012, 47 (05): : 563 - 570
  • [98] Tapping RI, 2000, CHEM IMMUNOL, V74, P108
  • [99] DETERMINANTS OF PROGRESSION TO CIRRHOSIS OR FIBROSIS IN PURE ALCOHOLIC FATTY LIVER
    TELI, MR
    DAY, CP
    BURT, AD
    BENNETT, MK
    JAMES, OFW
    [J]. LANCET, 1995, 346 (8981) : 987 - 990
  • [100] EPIDEMIOLOGY OF CIRRHOSIS OF LIVER - NATIONAL MORTALITY DATA
    TERRIS, M
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1967, 57 (12): : 2076 - &